ICD120J ;ALB/RFS - YEARLY DRG UPDATE; August 15, 2024@15:24
;;18.0;DRG Grouper;**120**;October 20, 2000;Build 4
;Per VA Directive 6402, this routine should not be modified.
;Updates for DRGS 640-809
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.3281^3.6^5
;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7815^2.6^3.3
;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.2411^3.2^4.5
;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6573^5^6.4
;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.0335^3.4^4.2
;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.779^2.6^3.2
;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.607^6.3^8
;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.4722^5.4^6.1
;;652^11^SURG^KIDNEY TRANSPLANT^3.0712^4.3^4.8
;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.5742^10.1^13.8
;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.8219^5.3^6.4
;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.0772^3.3^3.9
;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.2577^5.1^7.4
;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.828^2.6^3.4
;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.5039^1.7^1.9
;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.5842^5.8^8
;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.3399^2.9^3.7
;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0266^1.8^2.1
;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^3.1194^7.2^10
;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.5273^3.5^4.7
;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.0798^1.7^2.1
;;665^11^SURG^PROSTATECTOMY WITH MCC^3.4334^7.9^10.8
;;666^11^SURG^PROSTATECTOMY WITH CC^1.6472^3.6^4.9
;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^1.0277^1.8^2.3
;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.9161^7.2^9.9
;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.5475^3.7^4.9
;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9556^1.9^2.4
;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.7236^4.2^5.9
;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^1.0943^1.5^1.8
;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^4.19^10.4^13.5
;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3083^5.5^7.3
;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.5652^2.9^3.8
;;682^11^MED^RENAL FAILURE WITH MCC^1.502^4.4^5.8
;;683^11^MED^RENAL FAILURE WITH CC^0.8889^3^3.8
;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6075^2.2^2.6
;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.8856^5.3^7.3
;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0526^3.2^4.2
;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.7242^1.8^2.3
;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1704^3.8^5
;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.8026^2.8^3.5
;;693^11^MED^URINARY STONES WITH MCC^1.4703^3.8^5.3
;;694^11^MED^URINARY STONES WITHOUT MCC^0.7814^2.1^2.7
;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.1277^3.6^4.7
;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.6917^2.3^2.9
;;697^11^MED^URETHRAL STRICTURE^0.9728^2.6^3.4
;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6809^4.8^6.3
;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.0198^3.2^4
;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.6941^2.2^2.8
;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^1.9405^2.2^3.2
;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.4824^1.3^1.5
;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.247^4.1^7
;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.5013^1.7^2.3
;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^1.9075^4.7^6.7
;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^0.8861^2.1^2.7
;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.4459^2.5^3.6
;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^0.9396^1.5^1.7
;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.2582^5.4^8.1
;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.4192^1.5^1.8
;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.8554^3.4^4.9
;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.2318^1.9^2.4
;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.7288^5^7.2
;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.1229^3.4^4.7
;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6568^2^3.3
;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.2631^3.9^5.3
;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.7443^2.4^3.1
;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.4693^4.5^6
;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8171^2.9^3.6
;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.1008^3.1^4.4
;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.6069^1.8^2.2
;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.1027^3^4.4
;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.2138^1.6^1.8
;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^3.9373^7.5^9.6
;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^1.9983^3.7^4.6
;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.5168^2.2^2.6
;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.9807^6.4^9.6
;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.8182^2.7^3.6
;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.3735^1.5^1.8
;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.8266^2.7^3.9
;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.1986^1.5^1.7
;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^1.9539^4.5^6.6
;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.0248^1.9^2.2
;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.6745^3^4.9
;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.9551^1.3^1.5
;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.3622^1.4^1.8
;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.5884^5.3^7.4
;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.2895^1.9^2.3
;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.8092^5.1^7
;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.1101^3.2^4.4
;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9549^2^2.4
;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.4152^4.8^6.3
;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.0193^3.5^4.5
;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6399^2.6^3
;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^0.9855^2.8^3.7
;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.6339^1.9^2.3
;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.0111^2.7^3.1
;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.3763^2.8^3.8
;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^1.0759^2.1^3
;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.7134^2.3^2.9
;;779^14^MED^ABORTION WITHOUT D&C^0.9347^2.4^3.3
;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^1.842^4.6^6.8
;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.083^3.1^4.3
;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.8749^2.5^2.9
;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.6158^4.2^6.4
;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.0618^3.3^4
;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.905^2.9^3.3
;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.8027^1.8^1.8
;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^5.945^17.9^17.9
;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^4.0601^13.3^13.3
;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.4498^8.6^8.6
;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^4.1706^4.7^4.7
;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4762^3.4^3.4
;;795^15^MED^NORMAL NEWBORN^0.1998^3.1^3.1
;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.0609^2.9^3.5
;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^0.9682^2.3^2.7
;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.9682^2.3^2.7
;;799^16^SURG^SPLENIC PROCEDURES WITH MCC^4.7545^7.2^9.9
;;800^16^SURG^SPLENIC PROCEDURES WITH CC^2.9136^4.4^6
;;801^16^SURG^SPLENIC PROCEDURES WITHOUT CC/MCC^1.6417^2.5^2.9
;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.5846^7.5^10.8
;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^1.7799^3.9^5.5
;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.1055^1.7^2.3
;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^0.9979^2.8^4.2
;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.7235^2.3^2.6
;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6372^2^2.2
;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.2904^5.3^7.4
;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2385^3.4^4.3
;;EXIT
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD120J 10445 printed Dec 13, 2024@01:47:31 Page 2
ICD120J ;ALB/RFS - YEARLY DRG UPDATE; August 15, 2024@15:24
+1 ;;18.0;DRG Grouper;**120**;October 20, 2000;Build 4
+2 ;Per VA Directive 6402, this routine should not be modified.
+3 ;Updates for DRGS 640-809
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
+1 ;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.3281^3.6^5
+2 ;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7815^2.6^3.3
+3 ;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.2411^3.2^4.5
+4 ;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6573^5^6.4
+5 ;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.0335^3.4^4.2
+6 ;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.779^2.6^3.2
+7 ;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.607^6.3^8
+8 ;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.4722^5.4^6.1
+9 ;;652^11^SURG^KIDNEY TRANSPLANT^3.0712^4.3^4.8
+10 ;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.5742^10.1^13.8
+11 ;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.8219^5.3^6.4
+12 ;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.0772^3.3^3.9
+13 ;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.2577^5.1^7.4
+14 ;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.828^2.6^3.4
+15 ;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.5039^1.7^1.9
+16 ;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.5842^5.8^8
+17 ;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.3399^2.9^3.7
+18 ;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0266^1.8^2.1
+19 ;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^3.1194^7.2^10
+20 ;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.5273^3.5^4.7
+21 ;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.0798^1.7^2.1
+22 ;;665^11^SURG^PROSTATECTOMY WITH MCC^3.4334^7.9^10.8
+23 ;;666^11^SURG^PROSTATECTOMY WITH CC^1.6472^3.6^4.9
+24 ;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^1.0277^1.8^2.3
+25 ;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.9161^7.2^9.9
+26 ;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.5475^3.7^4.9
+27 ;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9556^1.9^2.4
+28 ;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.7236^4.2^5.9
+29 ;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^1.0943^1.5^1.8
+30 ;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^4.19^10.4^13.5
+31 ;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3083^5.5^7.3
+32 ;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.5652^2.9^3.8
+33 ;;682^11^MED^RENAL FAILURE WITH MCC^1.502^4.4^5.8
+34 ;;683^11^MED^RENAL FAILURE WITH CC^0.8889^3^3.8
+35 ;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6075^2.2^2.6
+36 ;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.8856^5.3^7.3
+37 ;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0526^3.2^4.2
+38 ;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.7242^1.8^2.3
+39 ;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1704^3.8^5
+40 ;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.8026^2.8^3.5
+41 ;;693^11^MED^URINARY STONES WITH MCC^1.4703^3.8^5.3
+42 ;;694^11^MED^URINARY STONES WITHOUT MCC^0.7814^2.1^2.7
+43 ;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.1277^3.6^4.7
+44 ;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.6917^2.3^2.9
+45 ;;697^11^MED^URETHRAL STRICTURE^0.9728^2.6^3.4
+46 ;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6809^4.8^6.3
+47 ;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.0198^3.2^4
+48 ;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.6941^2.2^2.8
+49 ;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^1.9405^2.2^3.2
+50 ;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.4824^1.3^1.5
+51 ;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.247^4.1^7
+52 ;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.5013^1.7^2.3
+53 ;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^1.9075^4.7^6.7
+54 ;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^0.8861^2.1^2.7
+55 ;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.4459^2.5^3.6
+56 ;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^0.9396^1.5^1.7
+57 ;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.2582^5.4^8.1
+58 ;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.4192^1.5^1.8
+59 ;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.8554^3.4^4.9
+60 ;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.2318^1.9^2.4
+61 ;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.7288^5^7.2
+62 ;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.1229^3.4^4.7
+63 ;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6568^2^3.3
+64 ;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.2631^3.9^5.3
+65 ;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.7443^2.4^3.1
+66 ;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.4693^4.5^6
+67 ;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8171^2.9^3.6
+68 ;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.1008^3.1^4.4
+69 ;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.6069^1.8^2.2
+70 ;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.1027^3^4.4
+71 ;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.2138^1.6^1.8
+72 ;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^3.9373^7.5^9.6
+73 ;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^1.9983^3.7^4.6
+74 ;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.5168^2.2^2.6
+75 ;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.9807^6.4^9.6
+76 ;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.8182^2.7^3.6
+77 ;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.3735^1.5^1.8
+78 ;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.8266^2.7^3.9
+79 ;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.1986^1.5^1.7
+80 ;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^1.9539^4.5^6.6
+81 ;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.0248^1.9^2.2
+82 ;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.6745^3^4.9
+83 ;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.9551^1.3^1.5
+84 ;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.3622^1.4^1.8
+85 ;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.5884^5.3^7.4
+86 ;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.2895^1.9^2.3
+87 ;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.8092^5.1^7
+88 ;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.1101^3.2^4.4
+89 ;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9549^2^2.4
+90 ;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.4152^4.8^6.3
+91 ;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.0193^3.5^4.5
+92 ;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6399^2.6^3
+93 ;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^0.9855^2.8^3.7
+94 ;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.6339^1.9^2.3
+95 ;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.0111^2.7^3.1
+96 ;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.3763^2.8^3.8
+97 ;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^1.0759^2.1^3
+98 ;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.7134^2.3^2.9
+99 ;;779^14^MED^ABORTION WITHOUT D&C^0.9347^2.4^3.3
+100 ;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^1.842^4.6^6.8
+101 ;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.083^3.1^4.3
+102 ;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.8749^2.5^2.9
+103 ;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.6158^4.2^6.4
+104 ;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.0618^3.3^4
+105 ;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.905^2.9^3.3
+106 ;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.8027^1.8^1.8
+107 ;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^5.945^17.9^17.9
+108 ;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^4.0601^13.3^13.3
+109 ;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.4498^8.6^8.6
+110 ;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^4.1706^4.7^4.7
+111 ;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4762^3.4^3.4
+112 ;;795^15^MED^NORMAL NEWBORN^0.1998^3.1^3.1
+113 ;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.0609^2.9^3.5
+114 ;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^0.9682^2.3^2.7
+115 ;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.9682^2.3^2.7
+116 ;;799^16^SURG^SPLENIC PROCEDURES WITH MCC^4.7545^7.2^9.9
+117 ;;800^16^SURG^SPLENIC PROCEDURES WITH CC^2.9136^4.4^6
+118 ;;801^16^SURG^SPLENIC PROCEDURES WITHOUT CC/MCC^1.6417^2.5^2.9
+119 ;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.5846^7.5^10.8
+120 ;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^1.7799^3.9^5.5
+121 ;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.1055^1.7^2.3
+122 ;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^0.9979^2.8^4.2
+123 ;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.7235^2.3^2.6
+124 ;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6372^2^2.2
+125 ;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.2904^5.3^7.4
+126 ;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2385^3.4^4.3
+127 ;;EXIT
